C D Hillyer

592 total citations
10 papers, 478 citations indexed

About

C D Hillyer is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, C D Hillyer has authored 10 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in C D Hillyer's work include Hematopoietic Stem Cell Transplantation (5 papers), Hematological disorders and diagnostics (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). C D Hillyer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Hematological disorders and diagnostics (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). C D Hillyer collaborates with scholars based in United States. C D Hillyer's co-authors include S P Dix, John R. Wingard, Leonard T. Heffner, H. Kent Holland, E. Winton, Robert B. Geller, S M Devine, Rein Saral, C. Gilmore and Richard E. Mullins and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transfusion.

In The Last Decade

C D Hillyer

10 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C D Hillyer United States	8	333	115	89	60	58	10	478
Katy Lambert United States	7	310 0.9×	122 1.1×	152 1.7×	73 1.2×	34 0.6×	9	545
M Bouvier United States	11	427 1.3×	175 1.5×	126 1.4×	84 1.4×	67 1.2×	29	688
Olga Bessmertny United States	10	155 0.5×	55 0.5×	41 0.5×	85 1.4×	26 0.4×	17	364
P Hentschke Sweden	15	604 1.8×	255 2.2×	109 1.2×	69 1.1×	62 1.1×	25	791
Jane Keidan United Kingdom	7	437 1.3×	132 1.1×	32 0.4×	53 0.9×	102 1.8×	9	589
P Tansey United Kingdom	11	284 0.9×	127 1.1×	65 0.7×	36 0.6×	118 2.0×	31	458
Tadashi Maekawa Japan	11	276 0.8×	46 0.4×	85 1.0×	34 0.6×	94 1.6×	42	468
Claude Lemarié France	18	630 1.9×	232 2.0×	149 1.7×	55 0.9×	121 2.1×	62	904
Salem Alshemmari Kuwait	14	216 0.6×	96 0.8×	50 0.6×	31 0.5×	181 3.1×	48	575
Y Kadotani Japan	10	48 0.1×	47 0.4×	60 0.7×	12 0.2×	15 0.3×	35	345

Countries citing papers authored by C D Hillyer

Since Specialization

Citations

This map shows the geographic impact of C D Hillyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C D Hillyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C D Hillyer more than expected).

Fields of papers citing papers by C D Hillyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C D Hillyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C D Hillyer. The network helps show where C D Hillyer may publish in the future.

Co-authorship network of co-authors of C D Hillyer

This figure shows the co-authorship network connecting the top 25 collaborators of C D Hillyer. A scholar is included among the top collaborators of C D Hillyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C D Hillyer. C D Hillyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Schuetz, Audrey N., Krista L. Hillyer, John D. Roback, & C D Hillyer. (2004). Leukoreduction filtration of blood with sickle cell trait. Transfusion Medicine Reviews. 18(3). 168–176. 30 indexed citations

2.

Hillyer, C D, et al.. (2000). Thrombotic thrombocytopenic purpura: New insights in disease pathogenesis and therapy. Transfusion Medicine Reviews. 14(3). 244–257. 9 indexed citations

3.

Hillyer, C D, et al.. (1998). Uses of antithrombin III concentrate in congenital and acquired deficiency states. Transfusion. 38(5). 481–498. 43 indexed citations

4.

O’Toole, Kevin S., James W. Keller, Daniela Mauer, et al.. (1997). Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation. Bone Marrow Transplantation. 20(3). 219–225. 14 indexed citations

5.

Devine, Steve, RB Geller, Liming Lin, et al.. (1997). The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.. PubMed. 3(1). 25–33. 31 indexed citations

6.

Holland, H. Kent, S P Dix, Robert B. Geller, et al.. (1996). Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.. Journal of Clinical Oncology. 14(4). 1156–1164. 47 indexed citations

7.

Dix, S P, John R. Wingard, Richard E. Mullins, et al.. (1996). Association of busulfan area under the curve with veno-occlusive disease following BMT.. PubMed. 17(2). 225–30. 262 indexed citations

8.

Schultz, Alyssa B., Robert B. Geller, & C D Hillyer. (1995). The Role of Bone Marrow Transplantation in the Treatment of Myelodysplastic Syndromes. Journal of Hematotherapy. 4(4). 323–334. 2 indexed citations

9.

Winton, EF, et al.. (1994). Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model. Blood. 84(1). 65–73. 35 indexed citations

10.

Winton, EF, et al.. (1994). Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model. Blood. 84(1). 65–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact